ChromaDex Corporation
NASDAQ:CDXC
Overview | Financials
Company Name | ChromaDex Corporation |
Symbol | CDXC |
Currency | USD |
Price | 5.4 |
Market Cap | 412,469,820 |
Dividend Yield | 0% |
52-week-range | 1.36 - 7.97 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Robert N. Fried |
Website | https://www.chromadex.com |
An error occurred while fetching data.
About ChromaDex Corporation
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD